Abstract:There is an increasing body of knowledge regarding how COVID-19 may be associated with ocular disease of varying severity and duration. This article discusses the literature on the ocular manifestations associated with COVID-19, including appraisal of the current evidence, suggested mechanisms of action, associated comorbidities and risk factors, timing from initial infection to diagnosis and clinical red flags. The current literature primarily comprises case reports and case series which inevitably lack control groups and evidence to support causality. However, these early data have prompted the development of larger population-based and laboratory studies that are emerging. As new data become available, a better appraisal of the true effects of COVID-19 on the eye will be possible. While the COVID-19 pandemic was officially declared no longer a "global health emergency" by the World Health Organization (WHO) in May 2023, case numbers continue to rise. Reinfection with different variants is predicted to lead to a growing cumulative burden of disease, particularly as more chronic, multi-organ sequelae become apparent with potentially significant ocular implications. COVID-19 ocular manifestations are postulated to be due to three main mechanisms: firstly, there is a dysregulated immune response to the initial infection linked to inflammatory eye disease; secondly, patients with COVID-19 have a greater tendency towards a hypercoagulable state, leading to prothrombotic events; thirdly, patients with severe COVID-19 requiring hospitalisation and are immunosuppressed due to administered corticosteroids or comorbidities such as diabetes mellitus are at an increased risk of secondary infections, including endophthalmitis and rhino-orbital-mucormycosis. Reported ophthalmic associations with COVID-19, therefore, include a range of conditions such as conjunctivitis, scleritis, uveitis, endogenous endophthalmitis, corneal graft rejection, retinal artery and vein occlusion, non-arteritic ischaemic optic neuropathy, glaucoma, neurological and orbital sequelae. With the need to consider telemedicine consultation in view of COVID-19's infectivity, understanding the range of ocular conditions that may present during or following infection is essential to ensure patients are appropriately triaged, with prompt in-person ocular examination for management of potentially sight-threatening and life-threatening diseases.

Ophthalmic and Neuro-ophthalmic Manifestations of Coronavirus Disease 2019 (COVID-19)

Ophthalmologic manifestations in the posterior segment of the eye after coronavirus infection

Evaluation of Ocular Symptoms and Tropism of SARS‐CoV‐2 in Patients Confirmed with COVID‐19

POSTERIOR SEGMENT OCULAR FINDINGS IN CRITICALLY ILL PATIENTS WITH COVID-19

Ocular repercussions in COVID-19 patients: structural changes of the retina and choroid

COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19

Incidence and Clinical Characteristics of COVID-19 Ophthalmopathy Following the Termination of Dynamic Zero COVID-19 Strategy in China

Vitritis and Outer Retinal Abnormalities in a Patient with COVID-19

Ocular manifestations of COVID-19

Ophthalmic manifestations in the COVID-19 clinical spectrum

Features of Diseases of the Anterior Part of the Eye in Patients after COVID-19

Ocular Manifestations of COVID-19: A Systematic Review and Meta-analysis

Ophthalmic manifestations in patients recovered from COVID-19 in Mexico

Ocular Involvement in COVID-19: Conjunctivitis and More

Distant Ocular Manifestations after New Coronavirus Infection

Ophthalmic Manifestations in COVID-19 Patients, a Review

[Ocular manifestations of coronavirus infection COVID-19 (clinical observation)]

Acute bilateral retrobulbar optic neuritis - An atypical sequela of COVID-19

COVID-19 and Crossed Eye: A Case Report and Literature Review

COVID-19 Ocular Manifestations in the Early Phase of Disease

Acute Bilateral Optic Neuritis as a Sequela of COVID-19 Infection: A Case Report